Factors affecting the Turnaround Time for Manufacturing, Testing and Release of Cellular Therapy Products prepared at Multiple Sites in support of Multicenter Cardiovascular Regenerative Medicine Protocols – a Cardiovascular Cell Therapy Research Network (CCTRN) Study

BACKGROUND: Cellular therapy studies are often conducted at multiple clinical sites in order to accrue larger patient numbers. In many cases this necessitates use of localized Good Manufacturing Practices (GMP) facilities to supply the cells. To assure consistent quality, oversight by a quality assu...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Richman, Sara, Gee, Adrian P., McKenna, David, Traverse, Jay, Henry, Timothy, Fisk, Diann, Pepine, Carl, Bloom, Jeannette, Willerson, James, Prater, Karen, Zhao, David, Koç, Jane Reese, Anwaruddian, Saif, Taylor, Doris, Cogle, Christopher, Moyé, Lemuel, Simari, Robert, Skarlatos, Sonia
Format: Artigo
Język:Inglês
Wydane: 2012
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355200/
https://ncbi.nlm.nih.gov/pubmed/22320233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2011.03543.x
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy